It's Personal

Dec. 27, 2011
As an officer of my corporation, I am obligated to act in the best interest of the corporation. Even if I did not have to, I have always taken my professional responsibility very seriously. I don’t like anything that even smells inappropriate. How a particular business decision should impact me personally should be irrelevant. But is that possible?
As an officer of my corporation, I am obligated to act in the best interest of the corporation. Even if I did not have to, I have always taken my professional responsibility very seriously. I don’t like anything that even smells inappropriate. How a particular business decision should impact me personally should be irrelevant. But is that possible?

For many years, I was responsible for clinical strategy at Eclipsys. While there has been some turnover, I still have many good friends at “the new Allscripts.” Would I maintain these relationships if we went another way? I know and love the Sunrise Clinical Manager (SCM) product. I believe I could make that product sing. I always have one director with an advanced degree in “SCM,” and recruitment of the needed team would be fun and probably pretty easy, given the personal connections. The challenge of integrating the legacy Allscripts Enterprise application with the legacy Eclipsys product would be a good challenge. I am also a Chicago girl, and Allscripts is a Chicago company. It is the home team, and I know that we would get the requisite attention. On the other hand, it is not a single patient record—and that is something that is difficult to change.

Meanwhile, Epic is the darling of the industry. A successful implementation of Epicare is quite valuable on the resume. Plus, I really am a single-database kind of gal. I firmly believe that it will take that level of integration in order to really compete in the new world order—call it an ACO, value-based purchasing in healthcare, or any other buzz word. I like the Epic culture, and every single person I have met from there is crazy smart. It seems like a foundationally sound decision.On the other hand, we would be customer number 150. There is no special treatment coming, and the costs in both capital and staff to support are just staggering.

Finally, my organization has been with Meditech for a very long time, and I personally value that kind of history. They are newfound converts to the value of ambulatory care and physician alignment. I am not sure how strong their new religion is, but if there were some way to make the 6.0 product work in our environment, we could save a lot of money. Maybe even enough to build a building…maybe I can get my name on that building…?

So what is the correct answer? On what side should I personally land?

The answer for me is linked to the fact that I really like my job, and I am looking to be successful here far more than I am looking to enhance the resume. The decision made will be my bed. I will need to sleep in it. That means that getting broad input and buy-in to the decision is essential. When I think about what side I personally come down on, it has to be the right side—for the organization—which will then be the right one for me.

Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?